Disease | arteritis, giant cell |
Comorbidity | C0032533|polymyalgia rheumatica |
Sentences | 5 |
PubMedID- 26156043 | Objective: we sought to identify clinical features at diagnosis that can distinguish isolated polymyalgia rheumatica (pmr) without giant cell arteritis (gca) from pmr with gca, and clinical features at diagnosis of isolated pmr that can predict subsequent relapse and corticosteroid discontinuation. |
PubMedID- 23579169 | polymyalgia rheumatica is associated with giant cell arteritis more frequently than expected by chance alone. |
PubMedID- 25762574 | Fdg positron emission tomography of giant cell arteritis with polymyalgia rheumatica. |
PubMedID- 21950841 | giant cell arteritis with polymyalgia rheumatica associated with influenza vaccination. |
PubMedID- 21559981 | Purpose: the aim of this study was to conduct a systematic review and perform a meta-analysis on the diagnostic performances of (18)f-fluorodeoxyglucose positron emission tomography (fdg pet) for giant cell arteritis (gca), with or without polymyalgia rheumatica (pmr). |
Page: 1